Insider Transactions in Q1 2023 at Sangamo Therapeutics, Inc (SGMO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 25
2023
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
345
-0.26%
|
$345
$1.66 P/Share
|
|
Feb 25
2023
|
Rolf Andrew Ramelmeier EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
15,618
-8.27%
|
$31,236
$2.66 P/Share
|
|
Feb 25
2023
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
SELL
Payment of exercise price or tax liability
|
Direct |
5,128
-3.78%
|
$10,256
$2.66 P/Share
|
|
Feb 25
2023
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
SELL
Payment of exercise price or tax liability
|
Direct |
54,767
-8.07%
|
$109,534
$2.66 P/Share
|
|
Feb 25
2023
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
7,030
-4.99%
|
$14,060
$2.66 P/Share
|
|
Feb 25
2023
|
Jason D. Fontenot SVP, Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,559
-4.5%
|
$13,118
$2.66 P/Share
|
|
Feb 25
2023
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
9,834
-6.63%
|
$19,668
$2.66 P/Share
|
|
Feb 25
2023
|
David Mark Mc Clung EVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,745
-4.16%
|
$19,490
$2.66 P/Share
|
|
Feb 24
2023
|
Rolf Andrew Ramelmeier EVP, Technical Operations |
BUY
Grant, award, or other acquisition
|
Direct |
45,000
+19.24%
|
-
|
|
Feb 24
2023
|
Scott B. Willoughby SVP, GEN. COUNSEL & SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
42,750
+23.95%
|
-
|
|
Feb 24
2023
|
Sandy Macrae PRESIDENT, CEO AND DIRECTOR |
BUY
Grant, award, or other acquisition
|
Direct |
157,300
+18.82%
|
-
|
|
Feb 24
2023
|
Prathyusha Duraibabu SVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,438
+27.52%
|
-
|
|
Feb 24
2023
|
Jason D. Fontenot SVP, Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
42,750
+22.66%
|
-
|
|
Feb 24
2023
|
Nathalie Dubois Stringfellow SVP-CHIEF DEVELOPMENT OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
53,438
+26.48%
|
-
|
|
Feb 24
2023
|
David Mark Mc Clung EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
56,250
+19.35%
|
-
|